Female Fertility & Pregnancy Rapid Test Market by Device Type (Digital Devices, Line-Indicator Devices), Test Type (FSH Urine Test, HCG Blood Test, HCG Urine Test), Type, Distribution Channel - Global Forecast 2024-2030

Female Fertility & Pregnancy Rapid Test Market by Device Type (Digital Devices, Line-Indicator Devices), Test Type (FSH Urine Test, HCG Blood Test, HCG Urine Test), Type, Distribution Channel - Global Forecast 2024-2030


The Female Fertility & Pregnancy Rapid Test Market size was estimated at USD 1.95 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.72% to reach USD 3.29 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Female Fertility & Pregnancy Rapid Test Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Female Fertility & Pregnancy Rapid Test Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Female Fertility & Pregnancy Rapid Test Market, highlighting leading vendors and their innovative profiles. These include Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co., Inc., EGENS GROUP, Eurofins Scientific, Everly Health, Inc., Expedient Healthcare Marketing Private Limited, Genea Limited, Geratherm Medical AG, Novartis AG, OneCare Media, Prestige Consumer Healthcare Inc., Progyny, Inc., Quidel Corporation, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Female Fertility & Pregnancy Rapid Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

Device Type
Digital Devices

Line-Indicator Devices
Test Type
FSH Urine Test

HCG Blood Test

HCG Urine Test

LH Urine Test
Type
Fertility Rapid Test Kits

Pregnancy Rapid Test Kits
Distribution Channel
Drugstores

Gynecology & Fertility Clinics

Hypermarkets & Supermarkets

Online

Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Female Fertility & Pregnancy Rapid Test Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Female Fertility & Pregnancy Rapid Test Market?
3. What are the technology trends and regulatory frameworks in the Female Fertility & Pregnancy Rapid Test Market?
4. What is the market share of the leading vendors in the Female Fertility & Pregnancy Rapid Test Market?
5. Which modes and strategic moves are suitable for entering the Female Fertility & Pregnancy Rapid Test Market?PDF E-mail From Publisher (2-5)Users License


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Female Fertility & Pregnancy Rapid Test Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for the quick and self-contained test than the time-consuming lab-based test
5.1.1.2. Growing incidence of infertility and gynecological disorders
5.1.2. Restraints
5.1.2.1. Absurdity of choice due to the availability of too many options
5.1.2.2. Controversies and device-related issues
5.1.3. Opportunities
5.1.3.1. Technological advancements and attractive product features such as smartphone app connectivity
5.1.3.2. Increasing awareness about the kits in the developing economies
5.1.4. Challenges
5.1.4.1. Availability of alternative diagnostic tests, such as blood test and reagent-based laboratory test with fewer chances of error
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Female Fertility & Pregnancy Rapid Test Market, by Device Type
6.1. Introduction
6.2. Digital Devices
6.3. Line-Indicator Devices
7. Female Fertility & Pregnancy Rapid Test Market, by Test Type
7.1. Introduction
7.2. FSH Urine Test
7.3. HCG Blood Test
7.4. HCG Urine Test
7.5. LH Urine Test
8. Female Fertility & Pregnancy Rapid Test Market, by Type
8.1. Introduction
8.2. Fertility Rapid Test Kits
8.3. Pregnancy Rapid Test Kits
9. Female Fertility & Pregnancy Rapid Test Market, by Distribution Channel
9.1. Introduction
9.2. Drugstores
9.3. Gynecology & Fertility Clinics
9.4. Hypermarkets & Supermarkets
9.5. Online
9.6. Pharmacies
10. Americas Female Fertility & Pregnancy Rapid Test Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Female Fertility & Pregnancy Rapid Test Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Female Fertility & Pregnancy Rapid Test Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Atlas Medical GmbH
14.1.2. bioMérieux SA
14.1.3. Church & Dwight Co., Inc.
14.1.4. EGENS GROUP
14.1.5. Eurofins Scientific
14.1.6. Everly Health, Inc.
14.1.7. Expedient Healthcare Marketing Private Limited
14.1.8. Genea Limited
14.1.9. Geratherm Medical AG
14.1.10. Novartis AG
14.1.11. OneCare Media
14.1.12. Prestige Consumer Healthcare Inc.
14.1.13. Progyny, Inc.
14.1.14. Quidel Corporation
14.1.15. Thermo Fisher Scientific
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET RESEARCH PROCESS
FIGURE 2. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2023 VS 2030
FIGURE 3. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET DYNAMICS
FIGURE 7. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
FIGURE 8. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 12. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings